CLOV NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Clover Health Investments Corp · Healthcare · Healthcare Plans

Open interactive chart View report data
Latest close 4.17 USD
-3.5% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 34.9% above the Trend Line and sits at 64.6% of its 52-week range. The latest completed week returned -3.5%, after a -20.7% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is neither clearly cheap nor expensive. Options positioning is mixed with 42/100 conviction, while the latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal; earnings are due in 3d.

Setup score 44 out of 100
Latest Close 4.17 USD 31 Jul 2026
1W Return -3.5% latest completed week
4W Return -20.7% short-term follow-through
12W Return 33.7% quarterly tape
Trend Breadth 19.2% 10 of 52 weeks active
Volume Ratio 0.5x vs 13-week average
What is working
  • The trend backdrop is active with a 10-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 2 reversal markers appear in the recent smart-money tape.
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -3.5% Latest completed week; four-week move -20.7%. Indicator stack 45/51 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Mixed 42/100 conviction; expected move 6.9%. News sentiment 50/100 68 relevant articles in the latest sentiment read. Event risk 3d Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 34.9% above the Trend Line and sits at 64.6% of its 52-week range. The latest completed week returned -3.5%, after a -20.7% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.5x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.9312-week average 0.61

12-week confirmation

Trend active10/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.93Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers

No recent accumulation markers. 2 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -20.7% over four weeks, 33.7% over 12 weeks, and 50.0% over one year. The current trend has remained active for 10 consecutive weeks.

Performance by holding period

1W-3.5%
4W-20.7%
12W33.7%
26W86.2%
52W50.0%
Active trend streak10 weeks
Active weeks in one year10
Trend breadth19.2%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.38Latest activity-pressure read.
Pressure change-75.1%Four-week change in activity pressure.
Leadership32.00Latest relative-leadership reading.
RS change-49.7%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 82% Model confidence 78%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength23/100Blend of value, momentum, and quality. Underlying universe rank 78; rank 1 is best.
Value22/100Relative valuation strength. Underlying universe rank 79; rank 1 is best.
Quality21/100Profitability and accounting quality. Underlying universe rank 80; rank 1 is best.
Momentum86/100Medium-term price momentum. Underlying universe rank 15; rank 1 is best.
Growth86/100Revenue and earnings growth. Underlying universe rank 15; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
1.0x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
2.9%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
18.4%
Gross profit retained from each unit of revenue.
Operating margin
-2.6%
Operating profit retained from revenue.
Free-cash-flow margin
2.7%
Free cash flow generated from revenue.
Return on invested capital
-
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
48.7%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
2/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
1.3%
Net share repurchases relative to market value.
Shareholder yield
1.3%
Dividend yield plus net buyback yield.
Net debt / EBITDA
3.1x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningMixed

CLOV shows mixed options pressure with a 42/100 conviction score, put-call volume ratio of 1.18, expected move of 6.9%, and Sharemaestro trend signal active.

Conviction42/100
Expected move6.9%
Put/call volume1.18
Pressure1
Speculation41
Volatility84
Trend agreement93
Open options detail
Insider activity0 / 20

0 acquisitions and 20 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment50/100

Weighted news tone is neutral across 68 relevant articles.

9 positive · 52 neutral · 7 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings3dNext report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
Options expected move6.9%Nearest-chain priced movement where available.
52-week drawdown-25.4%Distance below the 52-week high.
13-week volatility10.0%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2612 weeks finished lower.
Best week+23.5%Week of 12 Jun.
Worst week-15.6%Week of 10 Jul.
Latest week-3.5%Week of 31 Jul.

Shape of recent returns

Strong gains11
Modest gains2
Flat weeks1
Modest losses5
Sharp losses7
Recent vol10.0%13-week weekly-return volatility.
Base vol11.2%52-week weekly-return volatility.
Up/down split25/26Count of positive and negative weeks in the 52-week window.
Average skew10.2% / -7.0%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape48/100

Trend, activity pressure, participation, and risk combine to a 48/100 tape read.

 Indicator analysis82/100

Latest 12-week confirmation: trend 10/12, activity pressure 12/12, relative leadership 12/12.

Activity pressure 0.93; 2 reversal markers Factors35/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 28; Small Cap Core rank 77 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options60/100

CLOV shows mixed options pressure with a 42/100 conviction score, put-call volume ratio of 1.18, expected move of 6.9%, and Sharemaestro trend signal active.

Mixed · Options-market disagreement · Expected move 6.9% Sentiment50/100

Weighted news tone is neutral across 68 relevant articles.

Clover Health Investments, Corp. (NASDAQ:CLOV) Given Consensus Rating of "Hold" by Brokerages Insiders0 / 20

0 acquisitions and 20 disposals in the latest 180-day insider tape.

 Earnings3d

Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20264.17 USD-3.5%3.09 USD2.46 USD0.3832.0018.4MOn
24 Jul 20264.32 USD-6.5%3.03 USD2.45 USD0.7338.0918.4MOn
17 Jul 20264.62 USD4.1%2.97 USD2.43 USD1.0845.8925.1MOn
10 Jul 20264.44 USD-15.6%2.90 USD2.40 USD1.2635.1731.0MOn
3 Jul 20265.26 USD-2.8%2.85 USD2.38 USD1.5163.6127.9MOn
26 Jun 20265.41 USD8.2%2.76 USD2.35 USD1.5171.7543.5MOn
19 Jun 20265.00 USD5.7%2.66 USD2.32 USD1.5453.3129.7MOn
12 Jun 20264.73 USD23.5%2.57 USD2.30 USD1.5849.5672.9MOn
5 Jun 20263.83 USD-3.8%2.49 USD2.27 USD1.5924.4830.9MOn
29 May 20263.98 USD12.1%2.45 USD2.25 USD1.6623.3443.3MOn
22 May 20263.55 USD2.3%2.44 USD2.23 USD1.5512.8631.7MOff
15 May 20263.47 USD11.2%2.45 USD2.22 USD1.4711.0053.3MOff
8 May 20263.12 USD15.1%2.42 USD2.20 USD1.00-1.3531.7MOff
1 May 20262.71 USD11.5%2.40 USD2.19 USD0.35-10.7028.4MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.